Skip to main content
. 2019 May 17;12:3729–3742. doi: 10.2147/OTT.S207930

Table 1.

Association between GBAS expression and the clinicopathological characteristics in OSCC patients

Characteristic No. of patients GBAS χ2 P-value
Low expression,
n (%)
High expression,
n (%)
Gender 0.714 0.398
 Male 51 24 (32.88) 27 (36.99)
 Female 22 8 (10.96) 14 (19.18)
Age (years) 0.002 0.964
 ≤60 34 15 (20.55) 19 (26.03)
 ≥60 39 17 (23.29) 22 (30.14)
Tumor size (cm) 1.721 0.190
 ≤5 36 13 (17.81) 23 (31.51)
 ≥5 37 19 (26.03) 18 (24.66)
TNM stage 0.714 0.398
 I + II 51 24 (32.88) 27 (36.99)
 III + IV 22 8 (10.96) 14 (19.18)
Tumor grade 9.591 0.002
 G1 33 21 (27.77) 12 (16.44)
 G2/G3 40 11 (15.07) 29 (39.73)
Lymph node metastasis 0.304 0.581
 Yes 43 20 (27.40) 23 (31.51)
 No 30 12 (16.44) 18 (24.66)
Distant metastasis 0.369 0.544
 Yes 18 9 (12.33) 9 (12.33)
 No 55 23 (31.51) 32 (43.84)
Local recurrence 14.656 <0.001
 Yes 39 9 (12.33) 30 (41.10)
 No 34 23 (31.51) 11 (15.07)